ENPNewswire-August 20, 2019--FDA approves new antibiotic to treat community-acquired
M2 PHARMA-August 20, 2019-The US FDA approves Xenleta (lefamulin) to treat community-acquired
Global Banking News-August 20, 2019-The US FDA approves Xenleta (lefamulin) to treat community-acquired
M2 EQUITYBITES-August 20, 2019-The US FDA approves Xenleta (lefamulin) to treat community-acquired
pneumonia (CAP) is the acute infection of the pulmonary parenchyma occurring in daily community life with simultaneous clinical and radiological consolidation in one or more lobes of the lungs.
Pseudomonas aeruginosa is a rare cause of community-acquired
pneumonia (CAP) in an immunocompetent host.
This important milestone signifies continued progress in the evaluation of the efficacy and safety of omadacycline, which has the potential to address this significant unmet need in this serious community-acquired
Objective: Worldwide, community-acquired
pneumonia (CAP) is a common infection that occurs in older adults, who may have pulmonary comorbidities, including chronic obstructive pulmonary disease (COPD).
Food and Drug Administration voted in favor of the approval of intravenous and oral omadacycline for the treatment of acute bacterial skin and skin structure infections, by a vote of 17-1, and community-acquired
bacterial pneumonia, by a vote of 14-4.
Clinical outcomes from community-acquired
pneumonia (CAP) vary widely, from complete recovery to death, and depend on the patient's age, comorbidities, and other underlying risk factors.
IANS New Delhi Multi Drug Resistant organisms that cause deadly infections are spreading resulting in community-acquired
infections, reveals a new study by city's Sir Ganga Ram Hospital (SRGH).
After the researchers controlled for clinical and demographic variables, the only significant predictor of community-acquired
MDRO was cancer (odds ratio, 2.3; 95% confidence interval, 1.02-5.2).